Frontlight ResearchEarly access
Taking people in SwedenPhase 1/2
Tests a treatment in people with kidney cancer and kidney failure
Tests a treatment in adults with spreading kidney cancer and end-stage kidney disease.
Key facts
- Who runs it
- Oncorena AB
- Where
- Solna, SwedenSee the siteAlso in 3 other countries, 4 sites
- Registry title
- Kidney cancer
- Status
- Recruiting
- Phase
- Phase 1/2
- People taking part
- 105 people, planned
- Started
- 24 Apr 2024
- Expected to end
- 31 Jan 2029
- Type of study
- Interventional
- Record updated
- 15 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with metastatic kidney cancer (clear cell or papillary type) who also have end-stage kidney disease.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Metastatic clear cell renal cell carcinoma or papillary renal cell carcinoma, together with end-stage renal disease
Where in Sweden
Also in 3 other countries, 4 sites
- Karolinska University HospitalSolna, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Tests a treatment in people with kidney cancer and kidney failureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 15 September 2026